- Tytuł:
- PHASE 1 STUDY OF JNJ‐67856633, A FIRST‐IN‐HUMAN MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).
- Autorzy:
- Temat:
-
CHRONIC lymphocytic leukemia
NON-Hodgkin's lymphoma
FLUDARABINE
DIFFUSE large B-cell lymphomas
ALEMTUZUMAB - Źródło:
- Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p131-132, 2p
Czasopismo naukowe